Found: 25
Select item for more details and to access through your institution.
Current prospects of hereditary adrenal tumors: towards better clinical management.
- Published in:
- Hereditary Cancer in Clinical Practice, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s13053-024-00276-6
- By:
- Publication type:
- Article
Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 561, doi. 10.3390/ijms20030561
- By:
- Publication type:
- Article
Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 143, doi. 10.3390/ijms18010143
- By:
- Publication type:
- Article
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer.
- Published in:
- In Vivo, 2021, v. 35, n. 2, p. 1211, doi. 10.21873/invivo.12371
- By:
- Publication type:
- Article
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib.
- Published in:
- In Vivo, 2020, v. 34, n. 5, p. 2859, doi. 10.21873/invivo.12113
- By:
- Publication type:
- Article
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 709, doi. 10.21873/invivo.11828
- By:
- Publication type:
- Article
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
- Published in:
- Cancer Reports, 2021, v. 4, n. 2, p. 1, doi. 10.1002/cnr2.1322
- By:
- Publication type:
- Article
Availability of genome-matched therapy based on clinical practice.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 964, doi. 10.1007/s10147-024-02533-z
- By:
- Publication type:
- Article
Second morning urine method is superior to the casual urine method for estimating daily salt intake in patients with hypertension.
- Published in:
- Hypertension Research, 2012, v. 35, n. 6, p. 611, doi. 10.1038/hr.2012.6
- By:
- Publication type:
- Article
Tumor growth rate as a prognostic factor for metastatic or recurrent adenoid cystic carcinoma of the head and neck patients treated with carboplatin plus paclitaxel.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2021, v. 278, n. 8, p. 3037, doi. 10.1007/s00405-020-06481-y
- By:
- Publication type:
- Article
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6266, doi. 10.3390/cancers13246266
- By:
- Publication type:
- Article
Bone Marrow Transplantation for Hematologicai Diseases in Hokkaido—June 1985 to December 1991.
- Published in:
- Japanese Journal of Clinical Oncology, 1993, v. 23, n. 3, p. 166
- By:
- Publication type:
- Article
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients.
- Published in:
- Endocrine (1355008X), 2022, v. 76, n. 1, p. 70, doi. 10.1007/s12020-021-02963-z
- By:
- Publication type:
- Article
Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8377, doi. 10.2147/CMAR.S329581
- By:
- Publication type:
- Article
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4161, doi. 10.2147/CMAR.S249393
- By:
- Publication type:
- Article
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0280508
- By:
- Publication type:
- Article
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma.
- Published in:
- Endocrine Journal, 2021, v. 68, n. 12, p. 1383, doi. 10.1507/endocrj.ej21-0277
- By:
- Publication type:
- Article
Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.
- Published in:
- Endocrine Journal, 2021, v. 68, n. 6, p. 671, doi. 10.1507/endocrj.ej20-0762
- By:
- Publication type:
- Article
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
- Published in:
- Endocrine Journal, 2021, v. 68, n. 6, p. 639, doi. 10.1507/endocrj.ej20-0754
- By:
- Publication type:
- Article
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin.
- Published in:
- Oncology, 2022, v. 100, n. 4, p. 238, doi. 10.1159/000522303
- By:
- Publication type:
- Article
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 1, p. N.PAG
- By:
- Publication type:
- Article
An extragonadal germ cell tumor with dermatomyositis: A case report and literature review.
- Published in:
- Molecular & Clinical Oncology, 2020, v. 13, n. 5, p. N.PAG, doi. 10.3892/mco.2020.2130
- By:
- Publication type:
- Article
Current status of poly(ADP-ribose) polymerase inhibitors and future directions.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 5195, doi. 10.2147/OTT.S139336
- By:
- Publication type:
- Article
First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 15, p. 2348, doi. 10.1002/cncr.34788
- By:
- Publication type:
- Article